Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Neuroblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06574698
What this trial is testing

Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma

Who this might be right for
NeuroblastomaGD2 Antibody (Naxitamab)
Guangzhou Women and Children's Medical Center 64
Testing effectiveness (Phase 2)Looking for participantsNCT05135975
What this trial is testing

Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Who this might be right for
NeuroblastomaSarcoma
Nationwide Children's Hospital 86
Testing effectiveness (Phase 2)Study completedNCT00165139
What this trial is testing

Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas

Who this might be right for
NeuroblastomaEwings SarcomaNon-rhabdomyosarcoma Soft Tissue Sarcoma
Dana-Farber Cancer Institute 20
Early research (Phase 1)Study completedNCT00003141
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors

Who this might be right for
Brain TumorsCentral Nervous System TumorsNeuroblastoma+1 more
Children's Oncology Group 94
Testing effectiveness (Phase 2)Study completedNCT00578864
What this trial is testing

Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Baylor College of Medicine 13
Early research (Phase 1)Looking for participantsNCT06674265
What this trial is testing

Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma

Who this might be right for
Neuroblastoma, Recurrent, RefractoryNeuroblastoma (NB)Neuroblastoma in Children
Marzieh Ebrahimi 10
Post-approval studies (Phase 4)Study completedNCT00336531
What this trial is testing

Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
NeuroblastomaBrain TumorRetinoblastoma+2 more
Samsung Medical Center 100
Not applicableStudy completedNCT01418495
What this trial is testing

Pharmacokinetics of Ch14.18 in Younger Patients With High-Risk Neuroblastoma

Who this might be right for
Localized Resectable NeuroblastomaLocalized Unresectable NeuroblastomaNeurotoxicity Syndrome+4 more
National Cancer Institute (NCI) 12
Large-scale testing (Phase 3)Study completedNCT01041638
What this trial is testing

Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma

Who this might be right for
High Risk Neuroblastoma
National Cancer Institute (NCI) 105
Testing effectiveness (Phase 2)Study completedNCT00659984
What this trial is testing

N2007-01: Ultratrace™ Iobenguane I 131 in Patients With Relapsed/Refractory High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Molecular Insight Pharmaceuticals, Inc. 15
Early research (Phase 1)Looking for participantsNCT05272371
What this trial is testing

Immunotherapy With Dinutuximab Beta in Combination With Chemotherapy for the Treatment of Patients With Primary Neuroblastoma Refractory to Standard Therapy and With Relapsed or Progressive Disease

Who this might be right for
High-Risk Neuroblastoma
Jagiellonian University 20
Early research (Phase 1)Ended earlyNCT00670410
What this trial is testing

Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Columbia University 15
Large-scale testing (Phase 3)Study completedNCT00026312
What this trial is testing

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma

Who this might be right for
Localized Resectable NeuroblastomaLocalized Unresectable NeuroblastomaRecurrent Neuroblastoma+3 more
National Cancer Institute (NCI) 1,449
Testing effectiveness (Phase 2)Study completedNCT01467986
What this trial is testing

Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma

Who this might be right for
Neuroblastoma Recurrent
University of Regensburg 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT05421897
What this trial is testing

Rapid Administration Pilot for Infusing Dinutuximab

Who this might be right for
Neuroblastoma
Children's Hospital Los Angeles 30
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Testing effectiveness (Phase 2)Study completedNCT00003846
What this trial is testing

Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastoma
Children's Oncology Group 25
Early research (Phase 1)Study completedNCT00084422
What this trial is testing

N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 47
Early research (Phase 1)Study completedNCT00877110
What this trial is testing

Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma

Who this might be right for
NeuroblastomaBone Marrow, Sympathetic Nervous System
Memorial Sloan Kettering Cancer Center 71
Large-scale testing (Phase 3)Study completedNCT03042429
What this trial is testing

Combination Chemotherapy Followed by Stem Cell Transplant in High-risk Neuroblastoma Patients

Who this might be right for
Neuroblastoma
University of Cologne 360
Next Page